1141PDAssociation between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1. (23rd October 2018) - Kfoury, M; Voisin, A-L; Najean, M; Champiat, S; Laghouati, S; Michot, J-M; Robert, C; Mateus, C; Albiges, L; Besse, B; Massard, C; Texier, M; et al.